Medigen Vaccine Biologics Corporation

NT$46.90As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6547Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 7.86%
Div yield —
ROE (4.62%)
Biotechnology
Beta (5Y) 0.09
PE TTM —
TSR TTM 32.86%
Mkt cap NT$15.42B
ROIC (2.62%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$50
6.89%
(33.20%)
Hold 7|10|1|1|2
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.76
0.80
0.78
0.80
23.17%
29.15%
14.75%
9.74%
RevenueNT$B
1.751
1.736
1.819
1.834
3.83%
5.02%
5.85%
7.22%
Peers (US$465.7M)
Cap (US$)
PE
486.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.999
(0.100)
(0.096)
EBIT/Intx
1.083
0.149
0.130
Own earn%
86.34
16.40
44.76
Sh yield%
31.00
63.24
60.24
Owners
Insiders/Inst%
10.79
54.52
Short interest%
3.24
SBC / revenue%
1.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
7–14
$1 testx
—
Incr. ROIC%
16